Buscar
TherapeuticsMD Inc
TXMDAñadir a la lista de seguimiento
2.030USD
0.0000.00%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
23.50MCap. mercado
130.46P/E TTM
Más Datos de TherapeuticsMD Inc Compañía
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Información de TherapeuticsMD Inc
Símbolo de cotizaciónTXMD
Nombre de la empresaTherapeuticsMD Inc
Fecha de salida a bolsaJan 31, 2001
Director ejecutivoWalker (Marlan D)
Número de empleados1
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 31
Dirección951 Yamato Road, Suite 220
CiudadBOCA RATON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33431
Teléfono15619611900
Sitio Webhttps://www.therapeuticsmd.com/
Símbolo de cotizaciónTXMD
Fecha de salida a bolsaJan 31, 2001
Director ejecutivoWalker (Marlan D)
Ejecutivos de TherapeuticsMD Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de TherapeuticsMD Inc?
Los cinco principales accionistas de TherapeuticsMD Inc son: Mr. Marlan D. Walker, J.D.
¿Cuántas instituciones poseen acciones de TherapeuticsMD Inc (TXMD)?
A fecha de 2026Q1, 87 instituciones poseen acciones de TherapeuticsMD Inc, con un valor de mercado combinado de aproximadamente 3.82M, lo que representa el 32.99% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 423750.00.